Chiorean EG, Hurwitz HI, Cohen RB, Schwartz JD, Dalal RP, Fox FE, Gao L, Sweeney CJ.: Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. Ann Oncol 26 (6): 1230-7,2015.
Kaczmar John M, Tan Kay See, Heitjan Daniel F, Lin Alexander, Ahn Peter H, Newman Jason G, Rassekh Christopher H, Chalian Ara A, O'Malley Bert W, Cohen Roger B, Weinstein Gregory S: HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary surgery (TORS). Head & neck : 2014.
Mateo J, Berlin J, de Bono J S, Cohen R B, Keedy V, Mugundu G, Zhang Lianglin, Abbattista A, Davis C, Gallo Stampino C, Borghaei H: A first-in-human study of the anti-a5ß1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer chemotherapy and pharmacology 74 (5): 1039-46,2014.
Infante Jeffrey R, Dees E Claire, Olszanski Anthony J, Dhuria Shyeilla V, Sen Suman, Cameron Scott, Cohen Roger B: Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 32 (28): 3103-10,2014.
Lukens J Nicholas, Lin Alexander, Gamerman Victoria, Mitra Nandita, Grover Surbhi, McMenamin Erin M, Weinstein Gregory S, O'Malley Bert W, Cohen Roger B, Orisamolu Abimbola, Ahn Peter H, Quon Harry: Late consequential surgical bed soft tissue necrosis in advanced oropharyngeal squamous cell carcinomas treated with transoral robotic surgery and postoperative radiation therapy. International journal of radiation oncology, biology, physics 89 (5): 981-8,2014.